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OBJECTIVES We assessed the endothelial-dependent vasomotor function in nonrestenotic coronary arteries
more than six months following stent implantation, balloon angioplasty (BA), and directional
atherectomy (DCA).
BACKGROUND Catheter-based coronary interventions are associated with extensive arterial injury. Endothe-
lial function has been shown to remain chronically abnormal after vascular injury. The
long-term effects of different percutaneous coronary interventions on endothelial function are
not known.
METHODS Thirty-nine patients treated at least six months earlier with a coronary intervention for
isolated proximal left anterior descending (LAD) stenosis, with no evidence of restenosis,
were studied. Twelve patients had been stented, 15 had been treated with BA, and 12 had
undergone DCA. Changes in diameter of the intervened LAD, and the unintervened
circumflex coronary artery (Cx), in response to intracoronary acetylcholine infusions were
assessed by quantitative angiography.
RESULTS The groups had similar angiographic characteristics and risk factors for endothelial dysfunc-
tion. The LAD constricted significantly more (p 5 0.02) in previously stented patients
(221.8 6 4.3%), as compared to patients previously treated with BA (29.5 6 2.8%) or with
DCA (29.1 6 3.6%). In contrast, acetylcholine infusion resulted in mild constriction in the
Cx, which was similar in the three groups (p 5 0.47). By multiple regression analysis, previous
implant of a stent was the only significant predictor of LAD constriction (p 5 0.008).
CONCLUSIONS More severe endothelial dysfunction was observed long term after stenting as compared to BA
or DCA. These findings may have implications with respect to the progression of
atherosclerosis in coronary arteries subjected to percutaneous interventions. (J Am Coll
Cardiol 1999;34:1675–9) © 1999 by the American College of Cardiology
Catheter-based coronary interventions are associated with
extensive arterial wall injury (1). Although the endothelium
appears to regenerate after experimental vascular injury,
endothelium-dependent vasodilation remains impaired long
after endothelial regrowth (2,3). Consistent with this phe-
nomenon, studies in humans have demonstrated abnormal
endothelium-dependent vasomotion of the intervened ar-
tery several months after a coronary balloon angioplasty
(BA) (4–6).
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The long-term effects of different percutaneous coronary
interventions on endothelial function are not known. The
severity of endothelial dysfunction after a coronary inter-
vention may depend both on the severity of injury and the
specific type of percutaneous intervention. Coronary stent-
ing appears to cause a more severe arterial injury (7,8) and a
more intense inflammatory response within the vessel wall
than other modalities of percutaneous interventions (9,10).
Stenting may also be associated with incomplete endothelial
regrowth (11). Recent experimental evidence in porcine
coronary arteries indicates that stenting might be associated
with a more pronounced and prolonged endothelial dys-
function (12). In this study, the endothelial-dependent
vasomotor response was assessed long term following either
a successful coronary stent implantation, BA, or directional
atherectomy (DCA).
METHODS
Study population. Patients who had undergone a success-
ful percutaneous coronary intervention for a single proximal
left anterior descending (LAD) lesion at least six months
earlier were invited to participate in this study. Thirty-nine
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patients with no clinical or angiographic evidence of resten-
osis who had undergone BA, DCA, or stent implantation
were enrolled. Balloon angioplasty had been performed by
standard techniques. Directional atherectomy had been
performed using a standard atherectomy catheter (Devices
for Vascular Intervention, Redwood City, California). All
stented patients had received a single Palmaz-Schatz 15- or
18-mm stent (Johnson & Johnson, Warren, New Jersey),
deployed at high pressures (17.8 6 0.6 atm).
Clinical exclusion criteria were any coronary revascular-
ization since the initial coronary intervention; history of
coronary spasm; symptomatic congestive heart failure or
severe left ventricular dysfunction; insulin-dependent dia-
betes mellitus; and clinically significant renal or hepatic
disease. Patients with a diameter stenosis .50% in the left
coronary system were also excluded. The study protocol was
approved by the Committee on Human Subjects Experi-
mentation of the University of Toronto, and written in-
formed consent was obtained from all patients.
Study protocol. Patients had their cardiac medications
withdrawn 48 h before the study. Patients were allowed to
use sublingual nitroglycerin for angina, but no study was
performed within six hours of nitroglycerin use. Vitamin
supplements were discontinued for seven days.
Risk factors for endothelial dysfunction were assessed for
each patient at the time of the study. These factors included
age .45 years, male gender, previous diagnosis of hyper-
tension, non–insulin-dependent diabetes mellitus, current
cigarette smoking, family history of premature coronary
atherosclerosis, and total cholesterol .5.3 mmol/liter. Se-
rum lipids were evaluated in the fasting state at the time of
the study angiogram.
The research studies were performed at approximately
9:00 AM. Left coronary angiograms were performed by
power injection of 9 to 12 ml (3 to 4 ml/s) of nonionic
contrast medium in the control state and after serial acetyl-
choline infusions. Solutions were infused at 1.25 ml/min for
3 min into the left coronary artery via a diagnostic catheter
in the following sequence: 1) control (5% dextrose in water);
2) three incremental acetylcholine infusions: concentrations
of 1026, 1025, and 1024 molar; and 3) recontrol. Angiog-
raphy was repeated immediately after each infusion. A
3-min time period was allowed to elapse between each
angiogram and the following infusion, to compensate for
contrast medium-induced changes in coronary tone. Con-
stant angiographic technique was maintained throughout
the study. Heart rate, femoral arterial pressure, and electro-
cardiographic leads I, II, and V5 were continuously moni-
tored.
Quantitative angiography was performed by a blinded
technician, using an automated edge detection system
(CMS, Neunen, The Netherlands) as previously reported
(13). In our laboratory, coronary artery diameter measure-
ments performed with this system have interobserver vari-
ability of 0.09 mm, and intraobserver variability of 0.01 mm
on repeated analysis of the same frame.
A long, clearly visualized segment of the LAD distal to
the intervention site, and a segment of the nonintervened
circumflex coronary artery (Cx) were selected from the
control angiogram. Proximal and distal boundaries of the
selected segments were referenced to anatomical landmarks
to ensure replication of the analysis. The mean luminal
diameter of the entire segment was recorded from each of
the study angiograms. The average length of these segments
was 25.3 6 2.0 mm (LAD) and 19.2 6 1.8 mm (Cx).
Statistical analysis. Baseline characteristics were compared
using one-way analysis of variance (ANOVA) followed by
the Student-Newman-Keuls test for multiple comparisons
for continuous variables, or Kruskal-Wallis ANOVA on
ranks followed by the Dunn test for categorical variables.
Binary variables were analyzed by the Fisher exact test.
Changes in mean luminal diameter from control values to
maximal acetylcholine dose were compared using unbal-
anced ANOVA with post hoc (Student-Newman-Keuls)
tests for pairwise comparison whenever the general test was
significant. Multiple regression analysis was used to assess
predictors of the change in luminal diameter in response to
maximal acetylcholine infusion (SAS release 6.12, SAS
Institute, Cary, North Carolina). A two-sided p value
,0.05 was considered significant. Results are expressed as
mean 6 SE.
RESULTS
Baseline characteristics. Thirty-nine patients were stud-
ied: 15 patients previously treated with BA, 12 with DCA,
and 12 with coronary stenting (Table 1). The average time
from the index intervention to this study was 19 6 2
months. The study groups were well matched for baseline
characteristics. Current smoking was more prevalent among
DCA patients (p 5 0.05). Antioxidant vitamins were taken
more often by stented patients (p 5 0.05). Overall, no
significant difference existed in the total number of risk
factors for endothelial dysfunction among groups.
Angiographic characteristics. Quantitative angiography
of the proximal LAD before the remote intervention was
similar in the three groups (Table 2). Immediately after the
coronary intervention, the stent group had a significantly
smaller residual stenosis (p , 0.001) and a greater lumen
gain (p 5 0.02). At the time of the follow-up, the proximal
LAD in the three groups had similar angiographic charac-
teristics. As per protocol, no patient had significant LAD
Abbreviations and Acronyms
BA 5 balloon angioplasty
Cx 5 circumflex coronary artery
DCA 5 directional atherectomy
LAD 5 left anterior descending coronary artery
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stenosis. The average percent diameter stenosis of the
proximal LAD was approximately 20% for all groups (p 5
NS). Single-vessel coronary artery disease in the right
coronary artery was present in two previously stented pa-
tients, one with previous BA, and four with previous DCA.
Coronary responses to acetylcholine. All but three pa-
tients tolerated the intracoronary acetylcholine 1024 molar.
In two patients in the stent group and one in the BA group,
acetylcholine 1025 molar was the highest concentration
infused, as it caused severe coronary constriction associated
with chest pain. No further acetylcholine was administered
to these patients. The change in mean luminal diameter
from control values to maximal acetylcholine dose of the
LAD distal to the intervention site was significantly greater
(p 5 0.02) in patients who had previously undergone
stenting (221.8 6 4.3%) than in patient with previous BA
(29.5 6 2.8%), or DCA (29.1 6 3.6%) (Fig. 1 and 2). All
patients who had previously undergone stenting presented
some degree of constriction of the LAD, whereas the
response of patients with previous BA and DCA was mixed
(Fig. 3). In contrast, the response of the unintervened Cx to
acetylcholine was mild constriction, similar in all groups
(p 5 0.47).
By multiple regression analysis, stenting was the only
factor associated with LAD response to acetylcholine (p 5
0.008) (Table 3). No relationship was found between the
LAD responses and remote procedure luminal gain, time of
follow-up, total number of risk factors, and circumflex artery
response to acetylcholine.
DISCUSSION
This study examined the endothelium-dependent vasomo-
tor function of patients who had undergone a successful
percutaneous coronary intervention of the proximal LAD.
Table 1. Demographic, Clinical and Laboratory Characteristics of the Study Group
Stent
(n 5 12)
BA
(n 5 15)
DCA
(n 5 12) p Value
Age (yrs) 56.6 6 2.2 56.4 6 2.0 58.7 6 2.9 0.76
Gender (M/F) 12/0 12/3 12/0 0.10
Hypertension (n) 3 4 1 0.60
Non–insulin-dependent diabetes (n) 1 3 1 0.71
Family history of CAD (n) 5 4 6 0.43
Total cholesterol .5.3 mmol/liter (n) 2 3 4 0.56
Current smoker (n) 2 5 8 0.05
Total number of risk factors 3.0 6 0.2 3.0 6 0.3 3.6 6 0.3 0.44
Medical therapy
Vitamins E or C (n) 5 2 0 0.05
ACE inhibitors (n) 3 1 2 0.47
Lipid-lowering therapy (n) 6 4 3 0.43
ACE 5 angiotensin-converting enzyme; BA 5 balloon angioplasty; CAD 5 coronary artery disease; DCA 5 directional
coronary atherectomy. Risk Factors include male gender, age .45 years, hypertension, non–insulin-dependent diabetes, family
history of CAD, total cholesterol .5.3 mmol/liter, and current smoking.
Table 2. Quantitative Angiographic Data of the Proximal LAD, Pre- and Postintervention, and
at the Time of Study
Stent BA DCA
p
Value
Preintervention
Reference diameter (mm) 3.11 6 0.16 3.22 6 0.11 3.11 6 0.23 0.87
MLD (mm) 0.96 6 0.13 0.98 6 0.11 0.87 6 0.05 0.73
Diameter stenosis (%) 70.2 6 2.7 69.6 6 3.0 70.4 6 2.8 0.97
Postintervention
MLD (mm) 2.85 6 0.11 2.30 6 0.15 2.57 6 0.15 0.10
Diameter stenosis (%) 10.8 6 2.5* 30.0 6 3.9 23.8 6 3.2 ,0.001
Acute lumen gain (mm) 1.89 6 0.10† 1.17 6 0.19 1.70 6 0.25 0.02
At the time of study
Reference diameter (mm) 2.97 6 0.13 2.84 6 0.13 3.03 6 0.21 0.70
MLD (mm) 2.38 6 0.14 2.26 6 0.13 2.40 6 0.16 0.73
Diameter stenosis (%) 19.6 6 3.0 20.4 6 3.0 19.7 6 3.3 0.98
*Stent group versus BA and DCA groups. †Stent group versus BA group.
BA 5 balloon angioplasty; DCA 5 directional coronary atherectomy; MLD 5 minimal lumen diameter.
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Several months after the intervention, we found persistent
endothelial dysfunction in the intervened coronary artery.
More severe endothelium-dependent vasoconstriction was
observed in the LAD of stented patients than in the LAD
of patients who had undergone either BA or DCA. In
experimental studies, endothelial dysfunction after arterial
injury persists in the chronic regenerated state (2,3). Both
the degree and the duration of the endothelial dysfunction
appear to be proportional to the severity of the injury (14).
In humans, abnormal endothelium-dependent vasomotion
of the intervened coronary artery long after BA has been
previously reported (4–6).
Potential mechanisms of increased coronary constriction
to acetylcholine after stenting. We observed more severe
endothelial dysfunction in previously stented coronary ar-
teries. Similar findings have recently been reported in
porcine coronary arteries, where stenting was associated
with decreased endothelial integrity as compared to balloon
angioplasty for a period of 12 weeks (12). There are several
possible explanations for this finding. Stenting is associated
with larger luminal gain and more intense proliferative
response as compared to other coronary interventions (7,8).
Therefore, stenting probably causes more severe arterial
injury that might partially explain more severe endothelial
Figure 1. Percent change in mean luminal diameter of the left
anterior descending coronary artery (A) and circumflex artery (B)
from baseline, in response to intracoronary acetylcholine infusion.
*p 5 0.02 versus balloon angioplasty and directional atherectomy
groups. Open triangle 5 Stent group. Closed circle 5 Balloon
angioplasty group. Open square 5 Directional atherectomy group.
Figure 2. Representative coronary angiograms from patients previously treated with coronary stenting (A), balloon angioplasty (B), and
directional atherectomy (C) in the control state (Control) and after acetylcholine 1024 molar infusion (Ach 1024). Arrows indicate the
intervened left anterior descending artery.
Figure 3. Mean luminal diameter of the left anterior descending
coronary artery at baseline (C) and in response to maximal
intracoronary acetylcholine infusion (Ach) for all the study pa-
tients. BA 5 balloon angioplasty group; DCA 5 directional
coronary atherectomy group; Stent 5 stent group. *p 5 0.02 versus
balloon angioplasty and directional atherectomy groups.
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dysfunction. In addition, restoration of endothelial-
dependent vasomotion after injury is closely related to
endothelial regrowth (15). Although complete endothelial
regrowth has been observed after BA (14,16) this may not
be the case after stenting (11,12). Finally, there is growing
evidence that stenting is associated with increased inflam-
matory cell infiltration within the arterial wall (9,10,12).
Because inflammatory activation is associated with endothe-
lial dysfunction after vascular injury (16,17), an increased
inflammatory response to stenting might also explain the
more severe endothelial dysfunction observed.
Study limitations. There are limitations to this study.
Although the groups were well balanced in relation to
baseline characteristics, patients were not randomized to
receive the various forms of coronary intervention. Thus, it
is conceivable that these results are consequence of differ-
ences in baseline endothelial function among the groups. All
stented patients received a Palmaz-Schatz stent. It is un-
known whether these findings can be generalized to other
stents.
Conclusions. The long-term effects of stent implantation
into stenotic human coronary arteries are not well known.
Clinical and experimental evidence suggest that endothelial
dysfunction is implicated both in early atherogenesis and
later in the disease process. Our findings may, therefore,
have implications with respect to the progression of athero-
sclerosis in coronary arteries subjected to percutaneous
intervention, especially stent deployment. The observation
that implantation of foreign bodies in coronary arteries may
be associated with adverse consequences other than resten-
osis warrants further studies.
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